Skip to main content

Featured

Daily Markets Update: Nasdaq Hits Record as Yields Top 5.3%, TSX Flat, Loonie Near 70¢

  S&P/TSX 35,518.55 +0.04% S&P 500 7,773.99 +0.66% Nasdaq 27,477.31 +1.05% Brent US$100.42 -1.8% USD/CAD 1.4250 Flat US 10-yr 5.315% +3.8 bp Monday, October 5 close, with Asia’s Tuesday session. Wall Street’s tech rally pushed the Nasdaq to a fresh record on Monday even as long-term bond yields kept climbing: the U.S. 10-year Treasury yield settled at 5.315%, a new 52-week high. Canada’s TSX barely moved, with tech gains offsetting a slide in energy and financials, and Cenovus fell after unveiling a C$5.7-billion takeover of Athabasca Oil. Oil dropped nearly 2% as G7 emergency stock releases and rising Middle East exports eased supply fears, and the loonie hovered near 70 U.S. cents, close to its weakest level in about 18 months. Canada: TSX Flat as Tech Offsets Energy Index / Stock Close Change S&P/TSX Composite 35,518.55 +0.04% Shopify (SHOP) — +5.7% Athabasca Oil (ATH) — +13.5% Cenovus Energy (CVE) C$44.86 -3.0% Suncor Energy (SU) — -1.2% The TSX added 15.90 points ...

article

Provincial Directive Curbs AHS Authority Over Private Surgical Contract Negotiations

 


In a significant policy shift, Alberta Health Minister Adriana LaGrange has stripped Alberta Health Services (AHS) of its authority to negotiate contracts with private surgical facilities. According to a government directive obtained by media, the change came after internal concerns—raised by the agency’s then-chief executive—over rising contract costs.

Documents, including a letter from former AHS CEO Athana Mentzelopoulos’s lawyer, allege that senior government officials—even involving Premier Danielle Smith’s former chief of staff—intervened in AHS’s procurement process to favor private companies. This interference reportedly undermined AHS’s established negotiation powers and raised serious questions about transparency in the province’s health system. 

A separate report in a Morning Update from Unpublished Newswire reiterated the move, noting that the directive is part of broader reforms aimed at reducing costs by leveraging competitive pricing in surgical services.  Meanwhile, a CityNews investigation has added context to the controversy, citing denials by private surgical providers who label the allegations of sweetheart deals as “false and baseless.” 

Critics and opposition leaders are calling for further inquiry into the decision-making process behind these changes, arguing that the shift could signal a move toward greater privatization of public health services. In contrast, government representatives insist that the directive is intended solely to improve efficiency and ensure more competitive pricing for publicly funded operations.

Comments